3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Primary Myelofibrosis
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Interventions
pembrolizumab
5
Cyclophosphamide
4
Carboplatin
4
Filgrastim
3
fludarabine
2
Thiotepa
2
Temozolomide
2
Riluzole
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Immunohistochemistry
2
Drug Therapy
2
Counseling
2
Bupropion
2
vofatamab
1
utomilumab
1
trastuzumab deruxtecan
1
toripalimab
1
tasquinimod
1
sodium thiosulfate
1
sargramostim
1
saracatinib
1
poly ICLC
1
pertuzumab
1
liposomal doxorubicin
1
lenvatinib
1
ixabepilone
1
etoposide phosphate
1
durvalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
In Situ Hybridization, Fluorescence
×
Gynecologic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled